Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Spruce Biosciences, Inc. (SPRB) had Income from Continuous Operations of $-2.07M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-2.07M |
|
-- |
|
-- |
|
$2.69M |
|
$-2.69M |
|
$0.62M |
|
$-2.07M |
|
$-2.07M |
|
$-2.07M |
|
|
Income from Continuous Operations |
$-2.07M |
$-2.07M |
|
$-2.07M |
|
$-2.69M |
|
$-2.69M |
|
0.59M |
|
0.59M |
|
$-3.50 |
|
$-3.50 |
|
| Balance Sheet Financials | |
$20.95M |
|
-- |
|
$0.87M |
|
$21.82M |
|
$8.06M |
|
-- |
|
$0.58M |
|
$8.64M |
|
$13.18M |
|
$13.18M |
|
$13.18M |
|
0.56M |
|
| Cash Flow Statement Financials | |
$-21.55M |
|
-- |
|
$-0.81M |
|
$38.79M |
|
$16.42M |
|
$-22.37M |
|
$0.47M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.60 |
|
-- |
|
-- |
|
-- |
|
0.07 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-21.55M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-15.68% |
|
-15.68% |
|
-9.47% |
|
-15.68% |
|
$23.41 |
|
$-36.47 |
|
$-36.47 |
|